Literature DB >> 26755231

Oxidative stress among subjects with metabolic syndrome in Sokoto, North-Western Nigeria.

A A Sabir1, L S Bilbis, Y Saidu, A Jimoh, S O Iwuala, S A Isezuo, A U Kaoje, S A Abubakar.   

Abstract

BACKGROUND: Oxidative stress is known to play a role in the pathophysiology of metabolic syndrome and its components. Racial differences may exist in the level of markers of oxidative stress and antioxidants in patients with metabolic syndrome. AIM: The aim of this study was to determine the oxidative stress and antioxidants status in subjects with metabolic syndrome in Sokoto, North-Western Nigeria.
METHODS: A cross-sectional community-based study was carried out. Two hundred subjects (96 males and 104 females) were recruited for the study using a multi-stage sampling technique. Demographic data were obtained from the participants. Evaluation of anthropometric variables, blood pressure, blood glucose levels, lipid profiles, plasma insulin levels, total antioxidant status, and oxidative stress markers was performed.
RESULTS: The subjects with metabolic syndrome had significantly higher malondialdehyde as compared to those without metabolic syndrome (236.4 [92.2] vs. 184 [63.2] nmol/l). The antioxidant enzymes (superoxide dismutase, glutathione peroxidase and catalase) were significantly lower in subjects with metabolic syndrome than in those without metabolic syndrome (11.3 [4.2] vs. 13.9 [4.1] U/ml, 160[42] vs. 220[32] U/ml, and 2.12 [0.2] vs. 2.42 [0.2] U/ml, respectively). Similarly, the antioxidant Vitamins (A, C, and E) levels were significantly lower in subjects with metabolic syndrome than in those without metabolic syndrome (7.1 [4.1] vs. 7.7 [4.2] μmol/L, 225 [55.3] vs. 227.6 [62.3] μmol/L, and 75.9 [13.9] vs. 82.8 [18.6] mg/dl, respectively). There was a positive correlation between components of metabolic syndrome and free radicals.
CONCLUSION: Significantly increased oxidative stress and diminished antioxidant defenses were found among Nigerians with metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26755231     DOI: 10.4103/1119-3077.173705

Source DB:  PubMed          Journal:  Niger J Clin Pract            Impact factor:   0.968


  3 in total

1.  Oxidant/antioxidant status in Type-2 diabetes mellitus patients with metabolic syndrome.

Authors:  Ali Najafi; Morteza Pourfarzam; Fouzieh Zadhoush
Journal:  J Res Med Sci       Date:  2021-01-28       Impact factor: 1.852

2.  Increased Risk of Metabolic Syndrome in Patients with Vitiligo.

Authors:  Hatice Ataş; Müzeyyen Gönül
Journal:  Balkan Med J       Date:  2017-04-06       Impact factor: 2.021

3.  Fatty acid-binding protein 4 circulating levels in non-segmental vitiligo.

Authors:  Azza Gaber Antar Farag; Eman A E Badr; Asmaa El-Shafey Soliman El-Shafey; Mustafa Elsayed Elshaib
Journal:  An Bras Dermatol       Date:  2021-11-25       Impact factor: 1.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.